Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

4 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 3

2(25.0%)

Phase 4

2(25.0%)

8Total

N/A(4)

Phase 3(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT02306343Not ApplicableUnknown

Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the Experimental Device

Role: lead

NCT01368978Phase 3Completed

Pediatric Diabetics Type 1 Using InsuPatch

Role: lead

NCT01352767Phase 4Completed

The InsuPad in Daily Life Study - Effect of Local Heating on Postprandial Glucose Excursions Using the InsuPad Device

Role: lead

NCT01216618Phase 3Completed

Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies

Role: lead

NCT01283425Phase 4Completed

Evaluation of the Safety Use of the InsuPatch Device in Daily Life Conditions

Role: lead

NCT00767741Not ApplicableCompleted

Evaluation of the Effects of Heating or Massaging or Vibrating at the Vicinity of the Insulin Delivery Site

Role: lead

NCT01594801Not ApplicableCompleted

Testing the Effect of the InsuPad Device in Daily Life Conditions

Role: lead

NCT01114061Not ApplicableSuspended

Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the InsuPatch Device During Daily Life

Role: lead

All 8 trials loaded